Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

BRL 44408 MeSH Supplementary Concept Data 2025


MeSH Supplementary
BRL 44408
Unique ID
C072125
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C072125
Entry Term(s)
1H-Isoindole, 2-((4,5-dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-
2-((4,5-dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-1H-isoindole
BRL 48553
BRL 48962
BRL-44408
BRL-48553
BRL-48962
Pharm Action
Adrenergic alpha-Antagonists
Registry Numbers
ZET7B198W2
Related Numbers
118343-19-4
CAS Type 1 Name
2-(2H-(1-methyl-1,3-dihydroisoindole)methyl)-4,5-dihydroimidazole
Heading Mapped to
*Imidazoles
*Isoindoles
Frequency
80
Note
has selectivity for adrenergic alpha-2A receptors; BRL 48962 is the R-enantiomer; BRL 48553 is the R-enantiomer
Source
J Pharmacol Exp Ther 1991;259(3):1124
Date of Entry
1992/02/06
Revision Date
2017/07/24
BRL 44408 Preferred
2-((4,5-dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-1H-isoindole Broader
BRL 48553 Related
BRL 48962 Related
page delivered in 0.004s